Luxist Web Search

Search results

1. Results From The WOW.Com Content Network

2. Free COVID-19 vaccines may be harder to find this fall - AOL

   www.aol.com/free-covid-19-vaccines-may-140100609...

   COVID vaccines are significantly more expensive than most other vaccines. The price of a COVID-19 vaccine is $201.99 per dose for those who pay in cash, said Amy Thibault, a CVS spokeswoman.

3. The new COVID vaccine is here. Why these are the best times ...

   www.aol.com/news/covid-vaccine-why-best-times...

   Getting the COVID-19 vaccine now or in October will offer good protection against severe disease for at least a year, he said. But the best protection against infection is roughly six to eight ...

4. CVS offering COVID-19 booster shots to eligible populations ...

   www.aol.com/news/cvs-offering-covid-19-booster...

   Sep. 25—CVS Health said it is offering COVID-19 booster shots to eligible populations at 15 Longs Drugs locations in Hawaii, starting today. CVS said it is offering booster shots of the Pfizer ...

5. Operation Warp Speed - Wikipedia

   en.wikipedia.org/wiki/Operation_Warp_Speed

   On July 22, 2020, the U.S. government placed a conditional advance-purchase order of $2 billion with Pfizer to manufacture 100 million doses of a COVID-19 vaccine, with an option for 500 million more, for use in the United States if the vaccine was shown to be safe, effective, licensed, and authorized by the Food and Drug Administration (FDA).

6. Pfizer–BioNTech COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Pfizer–BioNTech_COVID-19...

   The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2][33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [45][46] It is authorized for use ...

7. COVID-19 vaccination in the United States - Wikipedia

   en.wikipedia.org/wiki/COVID-19_vaccination_in...

   The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.